ImportRefusal LogoImportRefusal

TAIZHOU MEDICAL CITY BIOBANK

⚠️ Moderate Risk

FEI: 3016807173 • Taizhou • CHINA

FEI

FEI Number

3016807173

📍

Location

Taizhou

🇨🇳

Country

CHINA
🏢

Address

Bldg G F 2, 103 China Medi, Taizhou, , China

Moderate Risk

FDA Import Risk Assessment

32.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
2
Unique Violations
6/1/2020
Latest Refusal
6/1/2020
Earliest Refusal

Score Breakdown

Violation Severity
70.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

24801×

RXPERSONAL

The article appears to be a device which requires a prescription from your doctor.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
6/1/2020
83QJRREAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID
2480RXPERSONAL
508NO 510(K)
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is TAIZHOU MEDICAL CITY BIOBANK's FDA import refusal history?

TAIZHOU MEDICAL CITY BIOBANK (FEI: 3016807173) has 1 FDA import refusal record(s) in our database, spanning from 6/1/2020 to 6/1/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. TAIZHOU MEDICAL CITY BIOBANK's FEI number is 3016807173.

What types of violations has TAIZHOU MEDICAL CITY BIOBANK received?

TAIZHOU MEDICAL CITY BIOBANK has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about TAIZHOU MEDICAL CITY BIOBANK come from?

All FDA import refusal data for TAIZHOU MEDICAL CITY BIOBANK is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.